Riik: Austraalia
keel: inglise
Allikas: APVMA (Australian Pesticides and Veterinary Medicines Authority)
ALUMINIUM HYDROXIDE; QUIL-A; RECOMBINANT GP70 SUB-TYPE A
INTERVET AUSTRALIA PTY LIMITED
feline leukaemia(102ug/dose)
MISC. VACCINES OR ANTI SERA
ALUMINIUM HYDROXIDE MINERAL-ALUMINIUM-BASE Active 3.0 mg/do; QUIL-A PLANT Active 10.0 ug/do; RECOMBINANT GP70 SUB-TYPE A VACCINE-ANTIGEN/ANTIBODY Active 102.0 ug/do
1 SD Vial; 10 SD Vls; 20 SD Vls; 25 SD Vls; 40 SD Vls; 5 SD Vials; 50 SD Vls; Vial=1.1mL
VM - Veterinary Medicine
INTERVET AUSTRALIA
CAT | CAT - QUEEN | CAT - TOM | KITTEN
IMMUNOTHERAPY
FELINE LEUKAEMIA VIRUS | DISEASE CAUSED BY
Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: CAT: [FELINE LEUKAEMIA VIRUS]; Poison schedule: 0; Withholding period: ; Host/pest details: CAT: [FELINE LEUKAEMIA VIRUS]; For the vaccination of cats against feline leukaemia virus (FeLV).AVOID USING in cats receiving corticosteroids. AVOID USING in pregnant queens
Registered
2023-07-01
INTERVET AUSTRALIA PTY LIMITED COMPANION FELV VACCINE AGAINST FELINE LEUKAEMIA VIRUS (FELV) COMPANY NAME: PRODUCT NAME: PRODUCT NO: LABEL NAME: COMPANION FELV VACCINE AGAINST FELINE LEUKAEMIA VIRUS (FELV) SIGNAL HEADINGS: FOR ANIMAL TREATMENT ONLY CONSTITUENT STATEMENTS: ACTIVE CONSTITUENTS: Each single dose vial (1.1 mL) contains: Recombinant gp70 sub-type A (vaccinal antigen) 102 micrograms / dose; Quil A (adjuvant) 10 micrograms / dose; Aluminium hydroxide (adjuvant) 3 milligrams / dose CLAIMS: For the vaccination of cats against feline leukaemia virus (FeLV). NET CONTENTS: 5 single dose vials 10 single dose vials 20 single dose vials 25 single dose vials 40 single dose vials 50 single dose vials single dose vials DIRECTIONS FOR USE: DIRECTIONS FOR USE: Only healthy cats possessing normal temperatures should be vaccinated. CONTRAINDICATIONS: CONTRAINDICATIONS: This product should not be used in cats receiving corticosteroids or in pregnant queens. DOSAGE AND ADMINISTRATION: DOSAGE AND ADMINISTRATION Note: The removable label should only be removed after the dose has been given. Primary vaccination subcutaneously or intramuscularly 2 doses of vaccine at a 2 to 3 week interval to cats 9 weeks of age or over. An annual booster is recommended. 56446/100867 RLP APPROVED For Official Use Only FIRST AID INSTRUCTIONS: First Aid If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126. FIRST AID WARNINGS: ADDITIONAL USER SAFETY: Additional User Safety Take care to avoid accidental self-injection. Accidental self-administration may result in local bruising, pain and swelling. In the event of self-administration, seek medical attention and show the package insert or label to the Medical Practitioner. Additional information is in the Material Safety Data Sheet. DISPOSAL: DISPOSAL Dispose of empty container by wrapping with paper and putting in garbage. Discarded needles should immediately be placed in a designated and appropriately labelled “sharps” container. STORAGE: STORAGE Store Lugege kogu dokumenti
PRODUCT NAME: COMPANION™ FELV VACCINE AGAINST FELINE LEUKEMIA VIRUS (FELV) MATERIAL SAFETY DATA SHEET THIS REVISION ISSUED: JULY, 2009 PAGE: 1 OF 5 MATERIAL SAFETY DATA SHEET Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461 (Business Hours) Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) SUBSTANCE: Companion FeLV Vaccine Against Feline Leukaemia Virus (FeLV). TRADE NAME: COMPANION™ FELV VACCINE AGAINST FELINE LEUKEMIA VIRUS (FELV) PRODUCT CODE: 3976 RECOMMENDED USE: For the vaccination of cats against Feline leukaemia virus (FeLV). APVMA NO: 56446 CREATION DATE: November, 2006 THIS VERSION ISSUED: July, 2009 and is valid for 5 years from this date. STATEMENT OF HAZARDOUS NATURE: THIS PRODUCT IS CLASSIFIED AS: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: None allocated. SUSDP CLASSIFICATION: None allocated. ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated PHYSICAL DESCRIPTION & COLOUR: Slightly turbid colourless liquid. ODOUR: No odour. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. INHALATION: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. However product may be mildly irritating, although unlikely to cause anything more than mild transient discomfort. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CONTACT: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. It should present no hazards in normal use. In addition product is unlikely to cause any discomfort in normal use. LONG TERM EXPOSURE: No data for health effects associated with long term skin exposure. EYE CONTACT: SHORT TERM EXPOSURE : This product may be mildly irritating to eyes, but is unlikely to cause anything more than mild discomfort which Lugege kogu dokumenti